Green Hygienics Holdings Inc. (OTCQB: GRYN)

Green Hygienics Holdings Inc. (GRYN) is a California-based innovative technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.

The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state of the art technologies, the company intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

Dedicated to creating the hemp industry’s safest and finest quality products, the company will be uniquely positioned to deliver product efficacy and supply chain solutions to consumers, as well as to leverage these within its own products and brand portfolio.

In September 2021, Green Hygienics produced its first annual ESG Report. Click here to view the report.

USDA Organic Certification and FDA Registration

On August 26, 2020, Green Hygienics registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002. This registration strengthens the company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike.

On September 30, 2020, Green Hygienics was granted USDA Organic Certification (7 CFR Part 205) for the cultivation and post-harvest processing of industrial hemp by the California Certified Organic Farmers for its Sol Valley Ranch property. This certification further enables the company to supply certified organic hemp products to national and international markets.

Market Opportunity

Green Hygienics is focused on finding, acquiring and developing strategically positioned businesses, as well as the best innovations within the hemp industry – a fast-progressing market with remarkable opportunities for growth. The industrial hemp market is expected to reach $5.33 billion in 2020 and is projected to rise to $15.26 billion by 2027, achieving a CAGR of 15.8%, per Grand View Research.

Capital Structure

GRYN has 44,126,138 shares outstanding, fully diluted. The company has just 7,247,706 common shares in float and boasts a balance sheet with no toxic debt or overhang.

Key Management

Todd Mueller is the CFO and interim Chief Executive Officer of Green Hygienics. He is an established professional who has held executive senior-level positions for both private and publicly traded companies during his 30-plus-year career. For the last half of those years, Todd has worked as a fractional CFO for various client companies and has provided his talents to build highly effective financial processes and procedures to handle rapid growth, provide discipline and leadership, and raise the appropriate financial capital to provide stability during all stages of the company’s life. Todd is regarded as a highly analytical decision-maker, experienced in building companies and with a proven history of generating corporate productivity. He has secured over $300 million in public offerings and over $100 million in private placement offerings.

Daniel Claycamp is the President and Director of Green Hygienics, and the Chief Executive Officer for Astra Holcomb Systems Inc. His 34 years of extensive executive experience have included management positions at top milling companies including Quaker Oats, Bunge, SEMO Milling, Didion Milling and United Maize, as well as the role of VP of Operations for GenCanna Global USA, an $83 million food-grade hemp processing facility. Dan has also successfully managed and directed teams to execute pathways for successful third party accreditations, licenses, permits, and compliance with large governing agencies like the FDA, USDA and OSHA.

Scott Slyker brings his entrepreneurial experience in the cannabis industry to Green Hygienics as the VP of Operations. His knowledge of various extraction and refinement techniques at scale and purification, separation, and isolation of various compounds in cannabis contributes to his capacity to move systems and innovative products forward. His reputation and dedication have led him to worldwide industry leaders like Carredi Supercritical and Alden Botanicals, where he we was involved in developing new state-of-the-art improvements in technology. Scott and his teams have managed several facility improvements and buildouts with optimization while staying cGNP compliant in Oregon, California, Nevada, Kentucky and South Carolina. As one of the first employees at Gencanna Global, he played a major role in developing many processes with Standard Operating Procedures on maintaining genetics, drying biomass, extraction, refinement, and isolate process and created products that were sold to top CBD brands like Medterra, My Daily Choice, Blue Moon Hemp, Hempworx, Green Roads and many others.

David Racz is the company’s Senior Vice President of Global Sales and Business Development. He has held global, senior level positions with Pfizer, GlaxoSmithKline and Novartis. As Vice President of Sales and Human Resources at Pfizer Pharmaceuticals he managed the largest expansion in Pfizer’s sales force history. Later, SmithKline Beecham recruited David to manage over 4,000 employees in sales, marketing, and research and development in 20 counties throughout Asia, Latin America, and Australia, as well as South Africa. He was also a key member of the team responsible for orchestrating the transcontinental merger of SmithKline and Beechman. Mr. Racz was also recruited by Novartis Pharmaceuticals as senior vice president North America and oversaw 14,000 global employees in pharmaceutical operations, global oncology, manufacturing and R&D.

Kyle MacKinnon serves as GRYN’s Chief Operating Officer. He has extensive knowledge in cannabis processing and was previously the Business Development Manager of Advanced Extraction Systems Inc., a leader in CO2 Supercritical Fluid Extraction. MacKinnon brings over 20 years of sales and management experience to the company.

Jerry Halamuda is the Senior Vice President of Business Development of the company’s Agriculture Division. He has an extensive career working in the agriculture and horticulture industry. Halamuda has founded, managed and operated multiple successful companies, including Color Spot Nurseries.

Investment Considerations
  • Green Hygienics owns the largest single USDA Certified Organic hemp farm in North America, with 824 acres of USDA Certified Organic outdoor cultivation potential and a further 400,000 square feet of greenhouse space. Green Hygienics is a real estate-backed investment with a valuation on the current farm property of $28 million.
  • The company has strong revenue growth potential by virtue of its acreage and ability to deliver products year-around through its indoor cultivation space (the average hemp farm in North America is approximately 15 acres). This, coupled with the direction the company is going with its own processing, directly addresses the need for a safe, secure supply chain solution for its target market – the nutraceutical, medical and pharmaceutical industries.
  • GRYN is a fully audited and SEC reporting company for full transparency.
  • GRYN is operated and managed by seasoned professionals with more than 200 years of direct collective experience of executing in this sector.
  • The company has a unique business model within the industry, putting it on a path to targeting the underserved nutraceutical, medical and pharmaceutical industries while addressing safety and efficacy issues.

Green Hygienics Holdings Inc. Website

facebook twitter LinkedIn Instagram